Scientists Develop Nicotine Vaccine to Curb Addiction
Scientists believe they may have come up with the vaccine to keep nicotine from reaching the human brain. They are hopeful that it will make the effort to quit smoking possible.
Article written by guest writer Rin Mitchell
What’s the Latest Development?
In an effort to cut tobacco addiction, researchers at Weill Cornell Medical College have developed a vaccine that “allows the body to make its own monoclonal antibodies against nicotine.” The moment the nicotine enters the bloodstream the vaccine eats it up before it even has a chance to get to the brain. There have been nicotine vaccines tested in the past, but they all failed clinical trials because “they all directly deliver nicotine antibodies, which only last a few weeks and require repeated, expensive injections.” The studies have only been conducted on mice, but researchers hope to test on humans in hopes that it will help the millions of smokers who are trying to quit. The vaccine will only be used for those who truly want to quit smoking. In addition, scientists are researching how the vaccine can be a preventative for people who never smoked before. Researchers think that parents might opt to give their children the vaccine just as they are able to do for HPV—in order to prevent them from smoking.
What’s the Big Idea?
Scientists have developed and tested a vaccine that will help tobacco smokers quit. The vaccine works to contain the nicotine, so it doesn’t make its way to the brain and trigger an addiction. Researchers believe the vaccine will not only help those trying to quit, but that it will be able “to preempt nicotine addiction in individuals who have never smoked, in the same way that vaccines are used now to prevent a number of disease-producing infections.”
Lumina Foundation is partnering with Big Think to unearth the next large-scale, rapid innovation in post-high school education. Enter the competition here!
Good science is sometimes trumped by the craving for a "big splash."
- Scientists strive to earn credit from their peers, for grants from federal agencies, and so a lot of the decisions that they make are strategic in nature. They're encouraged to publish exciting new findings that demonstrate some new phenomenon that we have never seen before.
- This professional pressure can affect their decision-making — to get acclaim they may actually make science worse. That is, a scientist might commit fraud if he thinks he can get away with it or a scientist might rush a result out of the door even though it hasn't been completely verified in order to beat the competition.
- On top of the acclaim of their peers, scientists — with the increasing popularity of science journalism — are starting to be rewarded for doing things that the public is interested in. The good side of this is that the research is more likely to have a public impact, rather than be esoteric. The bad side? To make a "big splash" a scientist may push a study or article that doesn't exemplify good science.
Moans, groans, and gripes release stress hormones in the brain.
Could you give up complaining for a whole month? That's the crux of this interesting piece by Jessica Hullinger over at Fast Company. Hullinger explores the reasons why humans are so predisposed to griping and why, despite these predispositions, we should all try to complain less. As for no complaining for a month, that was the goal for people enrolled in the Complaint Restraint project.
Participants sought to go the entirety of February without so much as a moan, groan, or bellyache.
Two space agencies plan missions to deflect an asteroid.
- NASA and the European Space Agency (ESA) are working together on missions to a binary asteroid system.
- The DART and Hera missions will attempt to deflect and study the asteroid Didymoon.
- A planetary defense system is important in preventing large-scale catastrophes.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.